Solara Active Pharma Sciences Limited

NSEI:SOLARA Stok Raporu

Piyasa değeri: ₹36.6b

Solara Active Pharma Sciences Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Poorvank Purohit

İcra Kurulu Başkanı

₹39.8m

Toplam tazminat

CEO maaş yüzdesi72.9%
CEO görev süresi1.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi1.8yrs
Yönetim Kurulu ortalama görev süresi1.3yrs

Son yönetim güncellemeleri

Recent updates

The Market Lifts Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares 26% But It Can Do More

Sep 13
The Market Lifts Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares 26% But It Can Do More

Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 30% Bounce

Jul 20
Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 30% Bounce

Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

May 11
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Apr 19
Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Mar 13
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Feb 23
Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Jan 04
Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

May 12
Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Nov 08
Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Sep 30
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Aug 03
Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Jun 19
Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

Feb 17
Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Dec 21
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

CEO Tazminat Analizi

Poorvank Purohit'un ücretlendirmesi Solara Active Pharma Sciences'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-₹5b

Jun 30 2024n/an/a

-₹6b

Mar 31 2024₹40m₹29m

-₹6b

Dec 31 2023n/an/a

-₹3b

Sep 30 2023n/an/a

-₹325m

Jun 30 2023n/an/a

-₹253m

Mar 31 2023₹5mn/a

-₹222m

Tazminat ve Piyasa: Poorvank 'nin toplam tazminatı ($USD 471.43K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 273.81K ).

Tazminat ve Kazançlar: Poorvank şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Poorvank Purohit (45 yo)

1.8yrs

Görev süresi

₹39,800,000

Tazminat

Mr. Poorvank Purohit serves as Chief Executive Officer of Solara Active Pharma Sciences Limited since February 03, 2023 and serves as its Director & Managing Director since July 2023. He started his career...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Poorvank Purohit
MD, CEO & Director1.8yrs₹39.80mVeri yok
Arun Baskaran
Chief Financial Officerless than a year₹700.00kVeri yok
Mohan Muthunarayanan
COO & Executive Director2.3yrs₹3.80mVeri yok
Suddapalli Krishna
Company Secretary6.7yrs₹4.80mVeri yok
Arun Pillai
Founder & Non-Executive Directorno dataVeri yok5.71%
₹ 2.1b
Hero Velladurai
Chief Scientific Officerless than a yearVeri yokVeri yok
V. Moorthy
Chief Quality Officerno dataVeri yokVeri yok

1.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: SOLARA 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.8 yıl), bu da yeni bir ekibin varlığını gösteriyor.


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Poorvank Purohit
MD, CEO & Director1.3yrs₹39.80mVeri yok
Mohan Muthunarayanan
COO & Executive Directorless than a year₹3.80mVeri yok
Arun Pillai
Founder & Non-Executive Director3.3yrsVeri yok5.71%
₹ 2.1b
Manish Gupta
Non-Executive Directorless than a yearVeri yokVeri yok
Kausalya Santhanam
Independent Director6.6yrs₹1.50mVeri yok
Ramakrishnan Rajagopal
Independent Chairman6.6yrs₹1.50m0.010%
₹ 3.8m
Rajendra Srivastava
Independent Directorless than a year₹200.00kVeri yok
Kartheek Raju
Non-Executive Non-Independent Director3.3yrsVeri yokVeri yok
Rajiv Nabar
Independent Directorless than a year₹400.00kVeri yok

1.3yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SOLARA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.3 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.